Amedeo Smart

Free Medical Literature Service

 

Amedeo

Antiretroviral Therapy
  Free Subscription

Articles published in
Antiviral Res
    March 2024
  1. MOON C, Porges E, Roberts A, Bacon J, et al
    A combination of nirmatrelvir and ombitasvir boosts inhibition of SARS-CoV-2 replication.
    Antiviral Res. 2024 Mar 14:105859. doi: 10.1016/j.antiviral.2024.105859.
    >> Share

  2. SCHREIBER A, Rodner F, Oberberg N, Anhlan D, et al
    The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the development of SARS-CoV-2 resistance.
    Antiviral Res. 2024 Mar 2:105840. doi: 10.1016/j.antiviral.2024.105840.
    >> Share

    December 2023
  3. ZUR M, Peselev T, Yanko S, Rotshild V, et al
    Efficacy and safety of antiviral treatments for symptomatic COVID-19 outpatients: Systematic review and network meta-analysis.
    Antiviral Res. 2023 Dec 4:105768. doi: 10.1016/j.antiviral.2023.105768.
    >> Share

    November 2023
  4. GALLUCCI L, Bazire J, Davidson AD, Shytaj IL, et al
    Broad-spectrum antiviral activity of two structurally analogous CYP3A inhibitors against pathogenic human coronaviruses in vitro.
    Antiviral Res. 2023;221:105766.
    >> Share

    June 2023
  5. CAI H, Yan J, Liu S, Li P, et al
    Paxlovid for hospitalized COVID-19 patients with chronic kidney disease.
    Antiviral Res. 2023 Jun 25:105659. doi: 10.1016/j.antiviral.2023.105659.
    >> Share

    February 2023
  6. LI J, Wang Y, Solanki K, Atre R, et al
    Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses.
    Antiviral Res. 2023 Feb 13:105555. doi: 10.1016/j.antiviral.2023.105555.
    >> Share

    November 2022
  7. CHEN X, Ding W, Cui X, Wei J, et al
    HIV protease inhibitor attenuated astrocyte autophagy involvement in inflammation via p38 MAPK pathway.
    Antiviral Res. 2022;208:105463.
    >> Share

    May 2022
  8. LIU T, Sun Q, Gu J, Cen S, et al
    Characterization of the tenofovir resistance-associated mutations in the hepatitis B virus isolates across genotypes A to D.
    Antiviral Res. 2022;203:105348.
    >> Share

    April 2022
  9. FOO CS, Abdelnabi R, Kaptein SJF, Zhang X, et al
    HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect.
    Antiviral Res. 2022;202:105311.
    >> Share

    November 2021
  10. JO EJ, Kim H, Konig A, Yang JW, et al
    Determination of infectious hepatitis B virus particles by an end-point dilution assay identifies a novel class of inhibitors.
    Antiviral Res. 2021 Nov 1:105195. doi: 10.1016/j.antiviral.2021.105195.
    >> Share

    July 2021
  11. ZHAO XA, Wang J, Liu J, Chen G, et al
    Baseline serum hepatitis B core antibody level predicts HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B after antiviral treatment.
    Antiviral Res. 2021 Jul 24:105146. doi: 10.1016/j.antiviral.2021.105146.
    >> Share

    April 2021
  12. ZHAO J, Guo S, Yi D, Li Q, et al
    A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase.
    Antiviral Res. 2021;190:105078.
    >> Share

    March 2021
  13. LIU Y, Chen R, Liu W, Si L, et al
    Investigation of multidrug-resistance mutations of hepatitis B virus (HBV) in a large cohort of chronic HBV-infected patients with treatment of nucleoside/nucleotide analogs.
    Antiviral Res. 2021 Mar 9:105058. doi: 10.1016/j.antiviral.2021.105058.
    >> Share

    January 2021
  14. ALOMAR FA, Tian C, Dash PK, McMillan JM, et al
    EFAVIRENZ, ATAZANAVIR, AND RITONAVIR DISRUPT SARCOPLASMIC RETICULUM Ca(2+) HOMEOSTASIS IN SKELETAL MUSCLES.
    Antiviral Res. 2021 Jan 12:104975. doi: 10.1016/j.antiviral.2020.104975.
    >> Share

    December 2020
  15. DALY MB, Sterling M, Holder A, Dinh C, et al
    The effect of depot medroxyprogesterone acetate on tenofovir alafenamide in rhesus macaques.
    Antiviral Res. 2020 Dec 29:105001. doi: 10.1016/j.antiviral.2020.105001.
    >> Share

    September 2020
  16. LI M, Zhou L, Dorsey HG, Musoff C, et al
    Tenofovir alafenamide does not inhibit mitochondrial function and cholesterol biosynthesis in human T lymphoblastoid cell line.
    Antiviral Res. 2020 Sep 24:104948. doi: 10.1016/j.antiviral.2020.104948.
    >> Share

  17. THEERAWATANASIRIKUL S, Kuo CJ, Phecharat N, Chootip J, et al
    Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.
    Antiviral Res. 2020 Sep 7:104927. doi: 10.1016/j.antiviral.2020.104927.
    >> Share

    July 2020
  18. OKAMOTO M, Toyama M, Baba M
    The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro.
    Antiviral Res. 2020 Jul 30:104902. doi: 10.1016/j.antiviral.2020.104902.
    >> Share

  19. PIZZORNO A, Padey B, Dubois J, Julien T, et al
    In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2.
    Antiviral Res. 2020 Jul 14:104878. doi: 10.1016/j.antiviral.2020.104878.
    >> Share

    June 2020
  20. CHEN R, Liu Y, Luo D, Si L, et al
    Hepatitis B virus mutation pattern rtA181S+T184I+M204I may contribute to multidrug resistance in clinical practice: Analysis of a large cohort of Chinese patients.
    Antiviral Res. 2020 Jun 19:104852. doi: 10.1016/j.antiviral.2020.104852.
    >> Share

  21. JOCKUSCH S, Tao C, Li X, Anderson TK, et al
    A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19.
    Antiviral Res. 2020;180:104857.
    >> Share

  22. GRUEVSKA A, Moragrega AB, Galindo MJ, Esplugues JV, et al
    p53 and p53-related mediators PAI-1 and IGFBP-3 are downregulated in peripheral blood mononuclear cells of HIV-patients exposed to non-nucleoside reverse transcriptase inhibitors.
    Antiviral Res. 2020;178:104784.
    >> Share

    April 2020
  23. CHOY KT, Yin-Lam Wong A, Kaewpreedee P, Sia SF, et al
    Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro.
    Antiviral Res. 2020 Apr 3:104786. doi: 10.1016/j.antiviral.2020.104786.
    >> Share

    January 2020
  24. LOZANO AB, Chueca N, de Salazar A, Fernandez-Fuertes E, et al
    Failure to Biktarvy(R) and development of resistance mutations in an antiretroviral-experienced patient.
    Antiviral Res. 2020 Jan 23:104717. doi: 10.1016/j.antiviral.2020.104717.
    >> Share

  25. JO E, Ryu DK, Konig A, Park S, et al
    Identification and characterization of a novel hepatitis B virus pregenomic RNA encapsidation inhibitor.
    Antiviral Res. 2020 Jan 12:104709. doi: 10.1016/j.antiviral.2020.104709.
    >> Share

    December 2019
  26. THEERAWATANASIRIKUL S, Kuo CJ, Phetcharat N, Lekcharoensuk P, et al
    In silico and in vitro analysis of small molecules and natural compounds targeting the 3CL protease of feline infectious peritonitis virus.
    Antiviral Res. 2019;174:104697.
    >> Share

  27. PANNEERPANDIAN P, Devanandan HJ, Marimuthu A, Karthikeyan C, et al
    Abacavir induces the transcriptional activity of YY1 and other oncogenic transcription factors in gastric cancer cells.
    Antiviral Res. 2019;174:104695.
    >> Share

  28. ZHANG H, Liu J, Zhu X, Li X, et al
    Safety, efficacy, and pharmacokinetics of pradefovir for the treatment of chronic hepatitis B infection.
    Antiviral Res. 2019 Dec 12:104693. doi: 10.1016/j.antiviral.2019.104693.
    >> Share

    October 2019
  29. GIACOMELLI A, Lai A, Franzetti M, Maggiolo F, et al
    No impact of previous NRTIs resistance in HIV positive patients switched to DTG+2NRTIs under virological control: Time of viral suppression makes the difference.
    Antiviral Res. 2019 Oct 17:104635. doi: 10.1016/j.antiviral.2019.104635.
    >> Share

    January 2019
  30. BARTOLO I, Borrego P, Gomes P, Goncalves F, et al
    In vitro evaluation of novel reverse transcriptase inhibitors TAF (tenofovir alafenamide) and OBP-601 (2,3-didehydro-3-deoxy-4-ethynylthymidine) against multi-drug resistant primary isolates of HIV-2.
    Antiviral Res. 2019;161:85-89.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016